Single-photon emission computed tomography myocardial perfusion imaging in patients with diabetes

Current Cardiology Reports

Volumn 7, Issue 2, 2005, Pages 117-123

  Noble, Gavin L ^b   Heller, Gary V ^a  

^a HARTFORD HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INSULIN SENSITIZING AGENT;

CARDIOVASCULAR RISK; CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ELECTROCARDIOGRAPHY; EPIDEMIC; HEART DEATH; HEART MUSCLE PERFUSION; HIGH RISK POPULATION; HUMAN; INCIDENCE; MORTALITY; PRACTICE GUIDELINE; PREDICTION; PREVALENCE; PROGNOSIS; REVIEW; RISK ASSESSMENT; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SILENT MYOCARDIAL ISCHEMIA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREADMILL EXERCISE; TREATMENT OUTCOME; ADULT; AGED; CARDIOVASCULAR DISEASE; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; FEMALE; HEART CATHETERIZATION; HEART MUSCLE ISCHEMIA; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PROSPECTIVE STUDY; RISK FACTOR; SCINTISCANNING;

ADULT; AGED; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; CORONARY DISEASE; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; ELECTROCARDIOGRAPHY; FEMALE; HEART CATHETERIZATION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 20644438468     PISSN: 15233782     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11886-005-0023-5     Document Type: Review

References (44)

1. American Diabetes Association: National Diabetes Fact Sheet on Diabetes in the United States in 2002. http://www.diabetes.org/diabetes-statistics/ national-diabetes-fact-sheet.jsp
2. Wild S, Roglic G, Green A, et al.: Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004, 27:1047-1053.
3. Sobel BE, Frye R, Detre KM: Bypass Angioplasty Revascularization Investigation 2 Diabetes Trial. Burgeoning dilemmas in the management of diabetes and cardiovascular disease: rationale for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial. Circulation 2003, 107:636-642.
4. American Heart Association: Heart Disease and Stroke Statistics- 2004 Update. Dallas: American Heart Association; 2003.
5. Wingard DL, Barrett-Connor EL, Scheidt-Nave C, McPhillips JB: Prevalence of cardiovascular and renal complications in older adults with normal or impaired glucose tolerance or NIDDM. A population-based study. Diabetes Care 1993, 16:1022-1025.
6. Grundy SM, Benjamin IJ, Burke GL, et al.: Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation 1999, 100:1134-1146.
7. Nesto RW, Phillips RT, Kett KG, et al.: Angina and exertional myocardial ischemia in diabetic and nondiabetic patients: assessment by exercise thallium scintigraphy. Ann Intern Med 1988, 108:170-175.
8. Haffner SM, Lehto S, Ronnemaa T, et al.: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998, 339:229-234.
9. Zuanetti G, Latini R, Maggioni AP, et al.: Influence of diabetes on mortality in acute myocardial infarction: data from the GISSI-2 study. J Am Coll Cardiol 1993, 22:1788-1794.
10. Laskey WK, Selzer F, Vlachos HA, et al.: Comparison of in-hospital and one-year outcomes in patients with and without diabetes mellitus undergoing percutaneous catheter intervention (from the National Heart, Lung, and Blood Institute Dynamic Registry). Am J Cardiol 2002, 90:1062-1067.
11. BARI Investigators: Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status. J Am Coll Cardiol 2000, 35:1122-1129.
12. Hachamovitch R, Berman DS, Kiat H, et al.: Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation 1996, 93:905-914.
13. Berman DS, Hachamovitch R, Kiat H, et al.: Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography. J Am Coll Cardiol 1995, 26:639-647.
14. Iskandrian AS, Chae SC, Heo J, et al.: Independent and incremental prognostic value of exercise single-photon emission computed tomographic (SPECT) thallium imaging in coronary artery disease. J Am Coll Cardiol 1993, 22:665-670.
15. Iskander S, Iskandrian AE: Risk assessment using single-photon emission computed tomographic technetium-99m sestamibi imaging. J Am Coll Cardiol 1998, 32:57-62.
16. Zatz R, Brenner BM: Pathogenesis of diabetic microangiopathy. The hemodynamic view. Am J Med 1986, 80:443-453.
17. Hasdai D, Gibbons RJ, Holmes DR Jr, et al.: Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects. Circulation 1997, 96:3390-3395.
18. Kang X, Berman DS, Lewin H, et al.: Comparative ability of myocardial perfusion single-photon emission computed tomography to detect coronary artery disease in patients with and without diabetes mellitus. Am Heart J 1999, 137:949-957.
19. Gu K, Cowie CC, Harris MI: Diabetes and decline in heart disease mortality in US adults. JAMA 1999, 281:1291-1297.
20. Felsher J, Meissner MD, Hakki AH, et al.: Exercise thallium imaging in patients with diabetes mellitus. Prognostic implications. Arch Intern Med 1987, 147:313-317.
21. Kang X, Berman DS, Lewin HC, et al.: Incremental prognostic value of myocardial perfusion single photon emission computed tomography in patients with diabetes mellitus. Am Heart J 1999, 138(6 Pt 1):1025-1032.
22. Navare SM, Noble GL, Ahmed SU, et al.: Risk stratification of diabetic patients with rest/stress ECG-gated Tc-99m sestamibi SPECT imaging: significance of mild perfusion abnormalities. J Am Col Cardiol 2004, 43:339A.
23. Giri S, Shaw LJ, Murthy DR, et al.: Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation 2002, 105:32-40.
24. Noble GL, Navare SM, Hussain SA, et al.: Progression of coronary artery disease in diabetics demonstrated by single isotope rest/stress Tc-99m sestamibi myocardial perfusion imaging: more rapid than non-diabetics? J Am Col Cardiol 2004, 43:340A.
25. Mosca L, Grundy SM, Judelson D, et al.: Guide to preventive cardiology for women. AHA/ACC scientific statement, consensus panel statement. Circulation 1999, 99:2480-2484.
26. Barrett-Connor EL, Cohn BA, Wingard DL, Edelstein SL: Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study. JAMA 1991, 265:627-631.
27. Amanullah AM, Berman DS, Erel J, et al.: Incremental prognostic value of adenosine myocardial perfusion single-photon emission computed tomography in women with suspected coronary artery disease. Am J Cardiol 1998, 82:725-730.
28. Berman DS, Kang X, Hayes SW, et al.: Adenosine myocardial perfusion single-photon emission computed tomography in women compared with men. Impact of diabetes mellitus on incremental prognostic value and effect on patient management. J Am Coll Cardiol 2003, 41:1125-1133.
29. Wenger NK: Coronary heart disease: the female heart is vulnerable. Prog Cardiovasc Dis 2003, 46:199-229.
30. Grundy SM, Garber A, Goldberg R, et al.: Prevention Conference VI: diabetes and cardiovascular disease: writing group IV: lifestyle and medical management of risk factors. Circulation 2002, 105:e153-e158.
31. Waller BF, Palumbo PJ, Lie JT, Roberts WC: Status of the coronary arteries at necropsy in diabetes mellitus with onset after age 30 years. Analysis of 229 diabetic patients with and without clinical evidence of coronary heart disease and comparison to 183 control subjects. Am J Med 1980, 69:498-506.
32. American Diabetes Association: Consensus development conference on the diagnosis of coronary heart disease in people with diabetes. Diabetes Care 1998, 21:1551-1559.
33. Passa P, Drouin P, Issa-Sayegh M, et al.: Coronary disease and diabetes. Diabetes Metab 1995, 21:446-451.
34. Langer A, Freeman MR, Josse RG, et al.: Detection of silent myocardial ischemia in diabetes mellitus. Am J Cardiol 1991, 67:1073-1078.
35. Chiariello M, Indolfi C, Cotecchia MR, et al.: Asymptomatic transient ST changes during ambulatory EGG monitoring in diabetic patients. Am Heart J 1985, 110:529-534.
36. Caracciolo EA, Chaitman BR, Forman SA, et al.: Diabetics with coronary disease have a prevalence of asymptomatic ischemia during exercise treadmill testing and ambulatory ischemia monitoring similar to that of nondiabetic patients. An ACIP database study. Circulation 1996, 93:2097-2105.
37. Milan Study on Atherosclerosis and Diabetes (MiSAD) Group: Prevalence of unrecognized silent myocardial ischemia and its association with atherosclerotic risk factors in non-insulin-dependent diabetes mellitus. Am J Cardiol 1997, 79:134-139.
38. Faglia E, Favales F, Calia P, et al.: Cardiac events in 735 type 2 diabetic patients who underwent screening for unknown asymptomatic coronary heart disease: 5-year follow-up report from the Milan Study on Atherosclerosis and Diabetes (MiSAD). Diabetes Care 2002, 25:2032-2036.
39. Janand-Delenne B, Savin B, Habib G, et al.: Silent myocardial ischemia in patients with diabetes: who to screen. Diabetes Care 1999, 22:1396-1400.
40. Vanzetto G, Halimi S, Hammoud T, et al.: Prediction of cardiovascular events in clinically selected high-risk NIDDM patients. Prognostic value of exercise stress test and thallium-201 single-photon emission computed tomography. Diabetes Care 1999, 22:19-26.
41. De Lorenzo A, Lima RS, Siqueira-Filho AG, Pantoja MR: Prevalence and prognostic value of perfusion defects detected by stress technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with diabetes mellitus and no known coronary artery disease. Am J Cardiol 2002, 90:827-832.
42. Miller TD, Rajagopalan N, Hodge DO, et al.: Yield of stress single-photon emission computed tomography in asymptomatic patients with diabetes. Am Heart J 2004, 147:890-896.
43. Miller TD, Rajagopalan N, Hodge DO, et al.: Stress single photon emission computed tomography can risk stratify asymptomatic diabetic patients. Circulation 2003, 108(S):IV-636.
44. Wackers FJ, Young LH, Inzucchi SE, et al.: Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care 2004, 27:1954-1961.